A dedicated company presentation track for regional Translational Research will be presented at the June 30th OneMedForum at the Roosevelt Hotel in midtown Manhattan. The track will showcase some of the science coming from the universities and hospitals in the New York Metropolitan area with the most promise to translate into lifesaving technologies and therapeutics. Directing this effort is Peter Leonardi, PhD., who led the business development and technology transfer program at New York Presbyterian Hospital, the University Hospital of Columbia and Cornell, where he helped found and incubate several medical device and healthcare information technology companies.
In addition to spotlighting the innovative medical technologies of tomorrow, the OneMedForum conference gives investors and life-science companies a chance to meet and mingle. This year’s conference will focus on opportunities in the European market. By staying confined to their homelands, both American and European investors may miss out on valuable opportunities to invest in overseas life-science companies. However, many American investors find it difficult to get a feel for the European market and may not know how to locate the most promising European life-science companies. The same can be said for European investors looking to penetrate the American market. Meanwhile, American and European companies might not even know where to begin searching for overseas funding. The OneMedForum will allow American investors to meet European companies, and European investors to meet American companies.
“OneMedForum chooses the right companies for the American investors and vice versa,” says Marcel Wijma, President and CEO of Van Leeuwenhoeck Research (VLR), an independent research company specializing in life science companies. VLR is inviting promising European companies to the June 30th conference. In the video below, Wijma explains how the OneMedForum can benefit investors and companies on both continents.